THIS ARTICLE IS SPONSORED BY NOVOCURE®.


This article includes expert insights from Moshe Giladi, PhD; and Narasimha Kumar Karanam, PhD, BCMAS. Giladi, Novocure’s Chief Science Officer, oversees Novocure’s preclinical research organization and manages external research partnerships and Novocure’s biostatistics and data management teams. Karanam is Novocure’s Medical Science Liaison and has researched the mechanisms of action underlying tumor treating fields therapy.

Exploring Tumor Treating Fields Therapy

Supplements and Featured Publications

Vol. 25 No. 16

OncologyLive® is the flagship publication of OncLive®. Each issue delivers expert insights and clinical oncology news and updates, which impact the day-to-day clinical practice of oncology professionals who work tirelessly to help improve patient outcomes.

Oncology Live®

February 2017

Precision Medicine in Oncology

IO - Immuno-Oncology - July 2022 Issue

Special Issues

Oncology Live Urologists in Cancer Care®: July 2023

Oncology Live Urologists in Cancer Care®

June 2017

Invited Presentations

November 2022

Oncology Treatment Pathways®

SABCS 2019: Updates in HER2+ Breast Cancer

Priority Report

Contemporary Oncology®: Biomarkers, Pathways, and Targeted Therapies® - January 2024

Contemporary Oncology®

March 2018

Contemporary Radiation Oncology

December 2015

Oncology & Biotech News

Oncology Business News®: April 2022

Oncology Business News®

Vol. 16 Issue 4

Oncology Fellows

November 2017

Oncology Nursing News

Onclive^® Publications

Legacy

Onclive® Publications

Legacy

Onclive^® Publications